Usefulness of Delayed Enhancement by Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy as a Marker of Disease and Its Severity

American Journal of Cardiology

Volumn 105, Issue 3, 2010, Pages 392-397

  Aquaro, Giovanni Donato ^a   Masci, Piergiorgio ^a   Formisano, Francesco ^b   Barison, Andrea ^c   Strata, Elisabetta ^a   Pingitore, Alessandro ^d   Positano, Vincenzo ^a   Spirito, Paolo ^b   Lombardi, Massimo ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM PENTETATE; SOTALOL;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 74049164244     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.09.045     Document Type: Article

References (14)

1. Choudhury L., Mahrholdt H., Wagner A., Choi K.M., Elliott M.D., Klocke F.J., Bonow R.O., Judd R.M., and Kim R.J. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
2. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.E., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
3. Adabag A.S., Maron B.J., Appelbaum E., Harrigan C.J., Buros J.L., Gibson C.M., Lesser J.R., Hanna C.A., Udelson J.E., Manning W.J., and Maron M.S. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
4. Olivotto I., Cecchi F., Gistri R., Lorenzoni R., Chiriatti G., Girolami F., Torricelli F., and Camici P.G. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1043-1048
5. Varnava A.M., Elliott P.M., Mahon N., Davies M.J., and McKenna W.J. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88 (2001) 275-279
6. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
7. Moon J.C. What is late gadolinium enhancement in hypertrophic cardiomyopathy. Rev Esp Cardiol 60 (2007) 1-4
8. Kuribayashi T., and Roberts W.C. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70 (1992) 1333-1340
9. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
10. Anderson K.R., Sutton M.G., and Lie J.T. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol 128 (1979) 79-85
11. Kim R.J., and Judd R.M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy in vivo imaging of the pathologic substrate for premature cardiac death?. J Am Coll Cardiol 41 (2003) 1568-1572
12. Wolff S.D., and Balaban R.S. Assessing contrast on MR images. Radiology 202 (1997) 25-29
13. Bogaert J., Goldstein M., Tannouri F., Golzarian J., and Dymarkowski S. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. AJR Am J Roentgenol 180 (2003) 981-985
14. Maron B.J., Spirito P., Shen W.K., Haas T.S., Formisano F., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Lawrenz T., Boriani G., Estes III N.A., Favale S., Piccininno M., Winters S.L., Santini M., Betocchi S., Arribas F., Sherrid M.V., Buja G., Semsarian C., and Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412